Hayley J McKee
Overview
Explore the profile of Hayley J McKee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
35
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Peace J, McKee H, Kopczynski C
Ophthalmol Ther
. 2020 Nov;
10(1):89-100.
PMID: 33244711
Introduction: Pharmacotherapy to lower intraocular pressure (IOP) is a mainstay of treatment aimed at delaying progression of visual field loss in ocular hypertension (OHT) and open-angle glaucoma (OAG), but some...
2.
Brubaker J, Teymoorian S, Lewis R, Usner D, McKee H, Ramirez N, et al.
Ophthalmol Glaucoma
. 2020 Aug;
3(5):327-338.
PMID: 32768361
Purpose: A phase 3 trial (MERCURY-1) investigated efficacy and safety of a once-daily, fixed-dose combination (FDC) of netarsudil and latanoprost, compared with each active component, in reducing elevated intraocular pressure...
3.
Strayer D, Agrawal L, Cordelier P, Liu B, Louboutin J, Marusich E, et al.
Mol Biotechnol
. 2006 Dec;
34(2):257-70.
PMID: 17172671
Among the goals of gene therapy is long-term expression of delivered transgenes. Recombinant Tagdeleted SV40 vectors (rSV40s) are especially well suited for this purpose. rSV40s deliver transgene expression that endures...
4.
Strayer D, Cordelier P, Kondo R, Liu B, Matskevich A, McKee H, et al.
Curr Gene Ther
. 2005 Apr;
5(2):151-65.
PMID: 15853724
The natural function of viruses is to deliver their genetic material to cells. Among the most effective of viruses in doing that is Simian Virus-40 (SV40). The properties that make...
5.
McKee H, Tsao P, Vera M, Fortes P, Strayer D
Genet Vaccines Ther
. 2004 Aug;
2(1):10.
PMID: 15324456
BACKGROUND: A vaccine that elicits durable, powerful anti-HIV immunity remains an elusive goal. In these studies we tested whether multiple treatments with viral vector-delivered HIV envelope antigen (gp120), with and...
6.
McKee H, Strayer D
Vaccine
. 2002 Sep;
20(29-30):3613-25.
PMID: 12297408
Vaccination protocols using viral gene delivery vectors have often generated relatively weak responses, largely owing to difficulties in boosting immune responses effectively following the primary injection. Because recombinant gene delivery...